By RICHARD FRANK Demand for GLP-1 medications soared last year and shows no signs of stopping in 2024. Employers and...
To account for differences in disease burden across a Medicare Advantage (MA) plans patient population, uses risk adjustment based on...
There are innumerable examples of when we have been faced with moments of great opportunity to make progress and failed...
It’s not uncommon for a patient, when searching their insurer’s provider directory, to find listings for physicians who are no...
By ROBBIE PEARL Soon after Apple released the original iPhone, my father, an unlikely early adopter, purchased one. His plan?...
Pepper Bio’s drug-hunting efforts have turned up its first clinical-stage drug candidate, but not by discovering a novel molecule in...
In July 2018, FDA released the Biosimilars Action Plan (BAP), which outlined FDA’s approach for...
To close Sexual Assault Awareness Month (SAAM), we are sharing this letter from Alison Barkoff, who leads ACL, Jeff Hild,...
Each April the U. S. Department of Health and Human Services (HHS) honors Second Chance Month, where we recognize the...
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee. The...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.